Zobrazeno 1 - 10 of 488 pro vyhledávání: '"Guay H"'
1
Akademický článek
Crohn's disease and ulcerative colitis share two molecular subtypes with different mechanisms and drug response.
Autor: Wang J; Genomic Research Center, AbbVie Inc, Cambridge, MA., Guay H; AbbVie Bioresearch Center, Worcester, MA., Chang D; Genomic Research Center, AbbVie Inc, Cambridge, MA.
Publikováno v: Journal of Crohn's & colitis [J Crohns Colitis] 2024 Oct 03. Date of Electronic Publication: 2024 Oct 03.
Zobrazit plný text záznamu
2
Akademický článek
HLA-DQA1*05 associates with anti-TNF immunogenicity and low adalimumab trough concentrations in inflammatory bowel disease patients from the SERENE UC and CD studies.
Autor: Reppell M; AbbVie Inc., North Chicago,IL., Zheng X; AbbVie Inc., North Chicago,IL., Dreher I; AbbVie Deutschland GmbH & Co. KG, Ludwigshafen., Blaes J; AbbVie Deutschland GmbH & Co. KG, Ludwigshafen., Regan E; AbbVie Inc., North Chicago,IL., Haslberger T; AbbVie Deutschland GmbH & Co. KG, Ludwigshafen., Guay H; AbbVie Inc., North Chicago,IL., Pivorunas V; AbbVie Inc., North Chicago,IL., Smaoui N; AbbVie Inc., North Chicago,IL.
Publikováno v: Journal of Crohn's & colitis [J Crohns Colitis] 2024 Aug 20. Date of Electronic Publication: 2024 Aug 20.
Zobrazit plný text záznamu
3
Akademický článek
Whole Blood DNA Methylation Changes Are Associated with Anti-TNF Drug Concentration in Patients with Crohn's Disease.
Autor: Lin S; Gastroenterology, Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK.; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK., Hannon E; University of Exeter Medical School, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK., Reppell M; Precision Medicine Immunology, AbbVie Inc., Chicago, IL, USA., Waring JF; Precision Medicine Immunology, AbbVie Inc., Chicago, IL, USA., Smaoui N; Precision Medicine Immunology, AbbVie Inc., Chicago, IL, USA., Pivorunas V; Precision Medicine Immunology, AbbVie Inc., Chicago, IL, USA., Guay H; Precision Medicine Immunology, AbbVie Inc., Chicago, IL, USA., Chanchlani N; Gastroenterology, Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK.; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK., Bewshea C; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK., Bai BYH; Genomics of Inflammation and Immunity Group, Wellcome Sanger Institute, Hinxton, UK.; Postgraduate School of Life Sciences, University of Cambridge, Cambridge, UK., Kennedy NA; Gastroenterology, Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK.; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK., Goodhand JR; Gastroenterology, Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK.; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK., Mill J; University of Exeter Medical School, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK., Ahmad T; Gastroenterology, Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK.; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK.
Publikováno v: Journal of Crohn's & colitis [J Crohns Colitis] 2024 Aug 14; Vol. 18 (8), pp. 1190-1201.
Zobrazit plný text záznamu
4
Akademický článek
Baseline TREM-1 Whole Blood Gene Expression Does Not Predict Response to Adalimumab Treatment in Patients with Ulcerative Colitis or Crohn's Disease in the SERENE Studies.
Autor: Verstockt B; Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.; Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium., Pivorunas V; Precision Medicine Immunology, AbbVie Bioresearch Centre, Worcester, MA, USA., Al Mahi N; Genomic Research Center, AbbVie, North Chicago, IL, USA., Smaoui N; Genomic Research Center, AbbVie, North Chicago, IL, USA., Guay H; Precision Medicine Immunology, AbbVie Bioresearch Centre, Worcester, MA, USA., Kennedy NA; Department of Gastroenterology, Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK., Goodhand JR; Department of Gastroenterology, Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK., Lin S; Department of Gastroenterology, Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK., Bai BYH; Genomics of Inflammation and Immunity Group, Wellcome Sanger Institute, Hinxton, UK., Hanauer SB; Department of Medicine, Northwestern University Feinberg School of Medicine, Evanston, IL, USA., Ferrante M; Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.; Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium., Panés J; Hospital Clinic de Barcelona, IDIBAPS, CIBERehd, Barcelona, Catalonia, Spain., Vermeire S; Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.; Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.
Publikováno v: Journal of Crohn's & colitis [J Crohns Colitis] 2024 Apr 23; Vol. 18 (4), pp. 493-505.
Zobrazit plný text záznamu
5
Akademický článek
Baseline Expression of Immune Gene Modules in Blood is Associated With Primary Response to Anti-TNF Therapy in Crohn's Disease Patients.
Autor: Bai BYH; Genomics of Inflammation and Immunity Group, Wellcome Sanger Institute, Hinxton, UK.; Postgraduate School of Life Sciences, University of Cambridge, Cambridge, UK., Reppell M; AbbVie Inc., Chicago, IL, USA., Smaoui N; AbbVie Inc., Chicago, IL, USA., Waring JF; AbbVie Inc., Chicago, IL, USA., Pivorunas V; AbbVie Inc., Chicago, IL, USA., Guay H; AbbVie Inc., Chicago, IL, USA., Lin S; Department of Gastroenterology, Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK.; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK., Chanchlani N; Department of Gastroenterology, Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK.; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK., Bewshea C; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK., Goodhand JR; Department of Gastroenterology, Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK.; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK., Kennedy NA; Department of Gastroenterology, Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK.; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK., Ahmad T; Department of Gastroenterology, Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK.; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK., Anderson CA; Genomics of Inflammation and Immunity Group, Wellcome Sanger Institute, Hinxton, UK.
Publikováno v: Journal of Crohn's & colitis [J Crohns Colitis] 2024 Mar 01; Vol. 18 (3), pp. 431-445.
Zobrazit plný text záznamu
6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
8
Akademický článek
Elevated Diaphragmatic Tonic Activity in PICU Patients: Age-Specific Definitions, Prevalence, and Associations.
Autor: Plante V; Division of Pediatric Intensive Care, Department of Pediatrics, Sainte-Justine Hospital, University of Montreal, Montreal, QC, Canada., Poirier C; Division of Pediatric Intensive Care, Department of Pediatrics, Sainte-Justine Hospital, University of Montreal, Montreal, QC, Canada., Guay H; Division of Pediatric Intensive Care, Department of Pediatrics, Sainte-Justine Hospital, University of Montreal, Montreal, QC, Canada., Said C; Division of Pediatric Intensive Care, Department of Pediatrics, Sainte-Justine Hospital, University of Montreal, Montreal, QC, Canada.; Department of Mathematics, Université Paris-Saclay, Paris, France., Sauthier M; Division of Pediatric Intensive Care, Department of Pediatrics, Sainte-Justine Hospital, University of Montreal, Montreal, QC, Canada., Al-Omar S; Division of Pediatric Intensive Care, Department of Pediatrics, Sainte-Justine Hospital, University of Montreal, Montreal, QC, Canada., Harrington K; Division of Pediatric Intensive Care, Department of Pediatrics, Sainte-Justine Hospital, University of Montreal, Montreal, QC, Canada., Emeriaud G; Division of Pediatric Intensive Care, Department of Pediatrics, Sainte-Justine Hospital, University of Montreal, Montreal, QC, Canada.
Publikováno v: Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies [Pediatr Crit Care Med] 2023 Jun 01; Vol. 24 (6), pp. 447-457. Date of Electronic Publication: 2023 Mar 08.
Zobrazit plný text záznamu
9
Akademický článek
The Clinical Response of Upadacitinib and Risankizumab Is Associated With Reduced Inflammatory Bowel Disease Anti-TNF-α Inadequate Response Mechanisms.
Autor: Wang J; Genomic Research Center, AbbVie Inc, Cambridge, MA, 02139, USA., Macoritto M; Genomic Research Center, AbbVie Inc, Cambridge, MA, 02139, USA., Guay H; AbbVie Bioresearch Center, Worcester, MA, 01605, USA., Davis JW; Genomic Research Center, AbbVie Inc, North Chicago, IL, 60064, USA., Levesque MC; AbbVie Cambridge Research Center, Cambridge, MA, 02139, USA., Cao X; Genomic Research Center, AbbVie Inc, Cambridge, MA, 02139, USA.
Publikováno v: Inflammatory bowel diseases [Inflamm Bowel Dis] 2023 May 02; Vol. 29 (5), pp. 771-782.
Zobrazit plný text záznamu
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje